Mr. Trimech from our Business Development Department will deliver an oral presentation at BioProcess International Asia, scheduled to be held from October 21^th (Mon.) to 23^th (Wed.) at The Westin Miyako Kyoto.

【Event Details】　https://informaconnect.com/bpi-asia/

【Presentation】
Date: October 23^th (Wed.) 4:30 PM – 5:00 PM
Venue: Westin Miyako Kyoto, Kyoto, Japan
Title: Pandemic Readiness, Sa-mRNA and LNP Technology Transfer, a US – Japan Collaboration
Presenter: Hamid Trimech (Business Development Department)

Abstract: In November 2023, MLHW, Japanese Health Authorities, approved the world’s 1st Sa-mRNA Covid-19 vaccine, Kostaive™. As part of the Japanese government pandemic readiness initiative, this new vaccine, developed in collaboration by Arcturus Therapeutics, CSL Seqirus and Meiji Seika Pharma will be manufactured locally in Japan. In September of 2023, a technology transfer of both the mRNA and LNP technologies to a newly established CDMO, ARCALIS Inc. was initiated with a target of completion by fall 2024. This presentation shares how mRNA and LNP manufacturing capability was established in record time and the methodology implemented, issues faced, and lessons learned throughout the transfer of Sa-mRNA/LNP technology to Japan.